ART Initiation Guidelines: WHO "Treat All" vs. CD4/Viral Load Thresholds

Antiretroviral therapy (ART) initiation criteria have evolved toward universal treatment, though guidelines vary by authority.

WHO (2021): "Treat All" Approach

Offer ART to all HIV-positive individuals regardless of CD4 count, viral load, or clinical stage. Goals: early viral suppression, reduced transmission, improved immune preservation, and simplified programmatic delivery.

DHHS (U.S.) & EACS (European): Threshold-Based Recommendations

While both now largely align with "treat all," historical and specific-context thresholds persist in some guidance:

  • Viral load ≥100,000 copies/mL: ART strongly recommended regardless of CD4.
  • CD4 <350 cells/µL: ART advised regardless of viral load.
  • For CD4 >350 and VL <100,000, individual factors drive decision-making.

Additional Decision Factors

  • Pregnancy (treat immediately)
  • Co-infections (TB, HBV, HCV)
  • Prior ART exposure/resistance
  • Patient readiness, adherence capacity, psychosocial stability
  • Age (>50 may warrant earlier start)

Practical Takeaway

Current global consensus favors rapid ART initiation—ideally within 7 days of diagnosis, same-day if possible. Guidelines update frequently; clinicians should consult the latest WHO, DHHS, or EACS documents and tailor decisions to each patient.

Viral Infections - Related Articles